Literature DB >> 23713304

[Comparative study on effect of acupuncture and lidocaine block for lumbar myofascial pain syndrome].

Gui-Mei Jiang1, Mou-De Lin, Lu-Ying Wang.   

Abstract

OBJECTIVE: To observe the clinical efficacy of acupuncture at Jiaji (EX-B 2) points mainly for lumbar myofascial pain syndrome (MPS).
METHODS: Sixty-six cases of MPS were randomized into an acupuncture group and a lidocaine group, 33 cases in each group. The acupuncture group was treated with acupuncture at Jiaji (EX-B 2) points combined with needling local myofascial trigger points (MTrP), and the lidocaine group was treated with local block at trigger points with lidocaine injection. The treatment was given once every 2 days. After three and five times of the treatment, the simplified McGill scale, Oswestry disability index (ODI) and pressure-pain threshold were assessed to compare the therapeutic effects between the two groups.
RESULTS: After treatment, the scores of simplified McGill and ODI of two groups were obviously reduced while the score of pressure-pain threshold was obviously increased (all P < 0.01). After three and five times of the treatment, there were no significant differences in above scores between the two groups (all P > 0.05).
CONCLUSION: Acupuncture at Jiaji (EX-B 2) points combined with needling MTrP is an effective and safe therapy for lumbar MPS, the therapeutic effect is equal to lidocaine block.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23713304

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

Review 1.  Myofascial low back pain treatment.

Authors:  Deepak Sharan; Joshua Samuel Rajkumar; Mathankumar Mohandoss; Rameshkumar Ranganathan
Journal:  Curr Pain Headache Rep       Date:  2014-09

Review 2.  Is dry needling effective for low back pain?: A systematic review and PRISMA-compliant meta-analysis.

Authors:  Han-Tong Hu; Hong Gao; Rui-Jie Ma; Xiao-Feng Zhao; Hong-Fang Tian; Lu Li
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.